PRKG1
PRKG1 (protein kinase cGMP-dependent 1, also known as PKG, PKG1, PGK, PRKGR1B and PRKG1B) is a serine/threonine protein kinase and a key mediator of the nitric oxide (NO)/cGMP signalling pathway. It phosphorylates many cellular proteins, many of which modulate cellular calcium. Browse Assay Genie's current range of PRKG1 research reagents below, or read on for the biology behind the target.
PRKG1 is a serine/threonine kinase that sits at the centre of the NO/cGMP signalling pathway. Binding of cyclic GMP activates the enzyme, which then phosphorylates serine and threonine residues on many cellular proteins. Many of these substrates influence intracellular calcium, although the contribution of each varies substantially between cell types. PRKG1 phosphorylates IRAG1 and so inhibits IP3-induced Ca(2+) release from intracellular stores. It also phosphorylates KCNMA1 (BKCa) channels, lowering intracellular Ca(2+) and increasing channel opening, and it phosphorylates members of the TRPC channel family, which inactivates the associated inward calcium current.
Through these and other substrates, PRKG1 regulates platelet activation and adhesion, smooth muscle contraction, cardiac function and gene expression. It also acts on feedback within the NO pathway and on CNS processes including axon guidance, hippocampal and cerebellar learning, circadian rhythm and nociception. Smooth muscle relaxation arises from lower free calcium, desensitisation of contractile proteins to calcium and reduced contractile state. PRKG1 also inactivates RhoA by phosphorylation, which reduces myosin light chain phosphorylation and promotes vasorelaxation, and it regulates VASP in platelets and smooth muscle. In smooth muscle cells, PRKG1 activity influences contractile protein expression and down-regulates osteopontin and thrombospondin-1, limiting cell migration.
The PRKG1 gene encodes the soluble Ialpha and Ibeta isoforms by alternative splicing. They share identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences, and so in dimerisation substrates and kinase activity. A separate gene, PRKG2, encodes the membrane-bound isoform II. PRKG1 is most strongly expressed in smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons and the lateral amygdala. It belongs to the AGC Ser/Thr protein kinase family, cGMP subfamily, and was formerly named protein kinase, cGMP-dependent, type I.
PRKG1 helps regulate cardiac function and smooth muscle relaxation, making it central to studies of vascular tone and vasorelaxation.
PRKG1 phosphorylates substrates such as VASP to regulate platelet activation and adhesion and to prevent platelet aggregation.
PRKG1 is expressed in Purkinje cells and hippocampal neurons and contributes to axon guidance, learning, circadian rhythm and nociception.
PRKG1 modulates intracellular calcium through IRAG1, BKCa and TRPC channel phosphorylation, a route for studying NO/cGMP-dependent calcium control.
PRKG1 is a cGMP-activated serine/threonine kinase and a key mediator of NO/cGMP signalling. It phosphorylates proteins that control calcium levels, smooth muscle contraction, platelet activation, cardiac function, gene expression and several CNS processes, including learning and nociception.
PRKG1 is also called PKG, PKG1, PGK, PRKGR1B and PRKG1B, and was previously named protein kinase, cGMP-dependent, type I. Alternative splicing produces the Ialpha and Ibeta isoforms, which differ in their zipper and autoinhibitory sequences. PRKG2 encodes a separate isoform II.
The mouse has an ortholog, Prkg1. The human protein is a cGMP-dependent kinase of the AGC family, cGMP subfamily, and mammals have three cGMP-dependent kinase isoforms. Check the datasheet of any product for its validated reactivity.
Other cGMP-dependent kinases, PRKG1 substrates and NO/cGMP signalling partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13976; product specifications from Assay Genie datasheets.